Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keybanc Maintains Overweight on Atlassian, Lowers Price Target to $210

Author: Benzinga Newsdesk | October 23, 2025 07:39am
Keybanc analyst Jason Celino maintains Atlassian (NASDAQ:TEAM) with a Overweight and lowers the price target from $250 to $210.

Posted In: TEAM

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist